Lesion of substantia nigra pars compacta by the GluR5 agonist ATPA

Brain Research

Volumn 955, Issue 1-2, 2002, Pages 104-114

  Vivó, Meritxell ^a   Camón, Llusa ^a   De Vera, Núria ^a   Martínez, Emili ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

ATPA; Dopaminergic neuron; GluR5; Kainate receptor; Lesion; Motor activity; Substantia nigra; Turning

Indexed keywords

ALPHA AMINO 5 TERT BUTYL 3 HYDROXY 4 ISOXAZOLEPROPIONIC ACID; GLUTAMATE RECEPTOR AGONIST;

ARTICLE; ASTROCYTE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG SELECTIVITY; GLIA CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NERVE CELL; NISSL STAINING; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; DOPAMINE; ISOXAZOLES; MALE; MOTOR ACTIVITY; NEURONS; PROPIONATES; RATS; RATS, WISTAR; RECEPTORS, KAINIC ACID; SUBSTANTIA NIGRA;

EID: 0037111276     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03373-5     Document Type: Article

References (59)

1. Acarín L., Vela J.M., González B., Castellano B. Demonstration of poly-N-acetyl lactosamine residues in ameboid and ramified microglial cells in rat brain by tomato lectin binding. J. Histochem. Cytochem. 42:1994;1033-1041.
2. Albin R.L., Makowiec R.L., Hollingsworth Z.R., Dure L.S., Penney J.B., Young A.B. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46:1992;35-48.
3. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
4. Ali A.B., Rossier J., Staiger J.F., Audinat E. Kainate receptors regulate unitary IPSCs elicited in pyramidal cells by fast-spiking interneurons in the neocortex. J. Neurosci. 21:2001;2992-2999.
5. Arnt J., Sánchez C., Lenz S.M., Madsen U., Krogsgaard-Larsen P. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity. Eur. J. Pharmacol. 285:1995;289-297.
6. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
7. Beninger R.J., Colton A.M., Ingles J.L., Jhamandas K., Boegman R.J. Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry. Neuroscience. 61:1994;603-612.
8. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:2000;1301-1306.
9. Bischoff S., Barhanin J., Bettler B., Mulle C., Heinemann S. Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon. J. Comp. Neurol. 379:1997;541-562.
10. Bezard E., Gross C.E. Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Prog. Neurobiol. 55:1998;93-116.
11. Blandini F., Greenamyre J.T. Prospects of glutamate antagonists in the therapy of Parkinson's disease. Fundam. Clin. Pharmacol. 12:1998;4-12.
12. Blandini F., Nappi G., Tassorelli C., Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol. 62:2000;63-88.
13. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
14. Camón L., De Vera N., Martínez E. Polyamine metabolism and glutamate receptor agonists-mediated excitotoxicity in the rat brain. J. Neurosci. Res. 66:2001;1101-1111.
15. Camón L., Vives P., De Vera N., Martínez E. Seizures and neuronal damage induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine. J. Neurosci. Res. 51:1998;339-348.
16. Campbell G.A., Eckardt M.J., Weight F.F. Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res. 333:1985;261-270.
17. Canteras N.S., Shammah-Lagnado S.J., Silva B.A., Ricardo J.A. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513:1990;43-59.
18. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
19. Chatha B.T., Bernard V., Streit P., Bolam J.P. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra. Neuroscience. 101:2000;1037-1051.
20. Chittajallu R., Braithwaite S.P., Clarke V.R., Henley J.M. Kainate receptors: subunits, synaptic localization and function. Trends Pharmacol. Sci. 20:1999;26-35.
21. Clarke V.R., Ballyk B.A., Hoo K.H., Mandelzys A., Pellizzari A., Bath C.P., Thomas J., Sharpe E.F., Davies C.H., Ornstein P.L., Schoepp D.D., Kamboj R.K., Collingridge G.L., Lodge D., Bleakman D. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature. 389:1997;599-603.
22. Cui C., Mayer M.L. Heteromeric kainate receptors formed by the coassembly of GluR5, GluR6, and GluR7. J. Neurosci. 19:1999;8281-8291.
23. Difazio M.C., Hollingsworth Z., Young A.B., Penney J.B. Jr. Glutamate receptors in the substantia nigra of Parkinson's disease brains. Neurology. 42:1992;402-406.
24. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51:1999;7-61.
25. Dusart I., Marty S., Peschanski M. Glial changes following an excitotoxic lesion in the CNS - II. Astrocytes. Neuroscience. 45:1991;541-549.
26. Fornaguera J., Schwarting R.K.W., Boix F., Huston J.P. Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model. Synapse. 13:1993;179-185.
27. Giardina S.F., Beart P.M. Excitotoxic profiles of novel, low-affinity kainate receptor agonists in primary cultures of murine cerebellar granule cells. Neuropharmacology. 41:2001;421-432.
28. Giménez-Llort L., De Vera N., Martínez E. Analysis of chemically-induced alterations of the motor activity in rats. Neurotoxicology. 19:1998;371-379.
29. Giménez-Llort L., Martínez E., Ferré S. Different effects of dopamine antagonists on spontaneous and NMDA-induced motor activity in mice. Pharmacol. Biochem. Behav. 56:1997;549-553.
30. Greenamyre J.T. Glutamatergic influences on the basal ganglia. Clin. Neuropharmacol. 24:2001;65-70.
31. Hefti F., Melamed E., Sahakian B.J., Wurtman R.J. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol. Biochem. Behav. 12:1980;185-188.
32. Hoo K., Legutko B., Rizkalla G., Deverill M., Hawes C.R., Ellis G.J., Stensbol T.B., Krogsgaard-Larsen P., Skolnick P., Bleakman D. [3H]ATPA: a high affinity ligand for GluR5 kainate receptors. Neuropharmacology. 38:1999;1811-1817.
33. Huettner J.E. Kainate receptors: knocking out plasticity. Trends Neurosci. 24:2001;365-366.
34. Isaacs K.R., Jacobowitz D.M. Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area. Exp. Brain Res. 99:1994;34-42.
35. Johnson A.E., Coirini H., Kallstrom L., Wiesel F.A. Characterization of dopamine receptor binding sites in the subthalamic nucleus. Neuroreport. 5:1994;1836-1838.
36. Kerchner G.A., Wilding T.J., Li P., Zhuo M., Huettner J.E. Presynaptic kainate receptors regulate spinal sensory transmission. J. Neurosci. 21:2001;59-66.
37. Kosinski C.M., Standaert D.G., Testa C.M., Penney J.B. Jr., Young A.B. Expression of metabotropic glutamate receptor 1 isoforms in the substantia nigra pars compacta of the rat. Neuroscience. 86:1998;783-798.
38. Lerma J., Paternain A.V., Rodríguez-Moreno A., López-García J.C. Molecular physiology of kainate receptors. Physiol. Rev. 81:2001;971-998.
39. Maisonnette S., Huston J.P., Brandao M., Schwarting R.K. Behavioral asymmetries and neurochemical changes after unilateral lesions of tuberomammillary nucleus or substantia nigra. Exp. Brain Res. 120:1998;273-282.
40. Martres M.P., Bouthenet M.L., Sales N., Sokoloff P., Schwartz J.C. Widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand. Science. 228:1985;752-755.
41. Marty S., Dusart I., Peschanski M. Glial changes following an excitotoxic lesion in the CNS - I. Microglia/macrophages. Neuroscience. 45:1991;529-539.
42. Moldrich R.X., Beart P.M., Pascoe C.J., Cheung N.S. Low-affinity kainate receptor agonists induce insult-dependent apoptosis and necrosis in cultured murine cortical neurons. J. Neurosci. Res. 59:2000;788-796.
43. Myers R.D., Hoch D.B. 14C-dopamine microinjected into the brain-stem of the rat: dispersion kinetics, site content and functional dose. Brain Res. Bull. 3:1978;601-609.
44. Ni Z., Bouali-Benazzouz R., Gao D., Benabid A.L., Benazzouz A. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat. Synapse. 40:2001;145-153.
45. Niquet J., Ben-Ari Y., Represa A. Glial reaction after seizure induced hippocampal lesion: immunohistochemical characterization of proliferating glial cells. J. Neurocytol. 23:1994;641-656.
46. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Lanciego J.L., Artieda J., Gonzalo N., Olanow C.W. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 23:2000;S8-19.
47. Paxinos G., Watson S. Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
48. Plaitakis A., Shashidharan P. Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease. J. Neurol. 247:(Suppl. 2):2000;II25-II35.
49. Pollack A.E. Anatomy, physiology, and pharmacology of the basal ganglia. Neurol. Clin. 19:2001;523-534.
50. Pycock C.J. Turning behaviour in animals. Neuroscience. 5:1980;461-514.
51. Robertson G.S., Robertson H.A. Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms. J. Neurosci. 9:1989;3326-3331.
52. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
53. Turski L., Jacobsen P., Honore T., Stephens D.N. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. J. Pharmacol. Exp. Ther. 260:1992;742-747.
54. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5:1968;107-110.
55. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367:1971;69-93.
56. Ungerstedt U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. Suppl. 367:1971;49-68.
57. Vignes M., Clarke V.R., Parry M.J., Bleakman D., Lodge D., Ornstein P.L., Collingridge G.L. The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus. Neuropharmacology. 37:1998;1269-1277.
58. Wüllner U., Standaert D.G., Testa C.M., Penney J.B., Young A.B. Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain. Brain Res. 768:1997;215-223.
59. Yung K.K. Localization of ionotropic and metabotropic glutamate receptors in distinct neuronal elements of the rat substantia nigra. Neurochem. Int. 33:1998;313-326.